M10.119
Lead-induced gout, unspecified shoulder
Clinical Classification Guidelines
Medical Intelligence & Overview
Lead-induced gout is a form of gout caused by exposure to lead, a toxic metal that can accumulate in the body over time. This condition leads to joint inflammation and pain, commonly affecting the shoulders among other joints. It is a specialized type of gout that results from lead poisoning, which can interfere with the body's ability to eliminate uric acid, leading to crystal formation in the joints. Recognizing and understanding lead-induced gout is essential for effective management and prevention of complications.
Causes & Symptoms
Clinical Causes: Chronic exposure to lead through occupational hazards, such as mining, painting, or manufacturing Living in areas with high environmental lead contamination Use of lead-containing products or traditional medicines that contain lead Inhalation or ingestion of lead particles, especially in areas with poor regulation and safety measures Accumulation of lead in the body over a prolonged period, disrupting normal metabolic processes related to uric acid handling
Key Symptoms: Joint pain, particularly in the shoulders, knees, ankles, and elbows Swelling and tenderness around affected joints Reduced joint mobility or stiffness Persistent discomfort or aching in joints, often worse at night Signs of lead toxicity such as abdominal pain, constipation, neurological symptoms like headache or cognitive disturbances (may coexist with gout symptoms)
Diagnostic & Treatment
Diagnosis Path: Diagnosing lead-induced gout involves a combination of medical history, physical examination, laboratory tests, and possibly imaging studies. Blood lead levels are measured to confirm lead exposure, while uric acid levels are assessed to evaluate gout. Joint aspiration may reveal needle-shaped uric acid crystals. Imaging techniques like X-rays can help identify joint damage or tophus formations. A comprehensive assessment helps distinguish lead-induced gout from other types of gout and joint disorders.
Treatment Protocols: Managing lead-induced gout requires a multifaceted approach, including: - Eliminating or reducing exposure to lead sources - Chelation therapy may be prescribed to remove excess lead from the body - Medication to control inflammation and pain, such as nonsteroidal anti-inflammatory drugs (NSAIDs) - Uric acid-lowering treatments like allopurinol or febuxostat - Supportive measures such as rest, joint immobilization, and physiotherapy - Ongoing monitoring of lead levels and uric acid as part of a comprehensive treatment plan Coordination with healthcare providers is crucial to address both lead poisoning and gout effectively.
Clinical Advice & FAQs
Billing Guidance
Is M10.119 a billable ICD-10 code?
Yes, M10.119 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M10.119?
Clinical documentation must specify the nature of Lead-induced gout, unspecified shoulder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference